Clinical and molecular detection of inherited colorectal cancers in northeast Italy A first prospective study of incidence of Lynch syndrome and MUTYH-related colorectal cancer in Italy

被引:4
|
作者
Urso, E. [1 ,2 ]
Agostini, M. [1 ,2 ,3 ,4 ]
Pucciarelli, S. [1 ,2 ]
Rugge, M. [5 ]
Bertorelle, R.
Maretto, I. [1 ,2 ]
Bedin, C. [1 ,2 ,4 ]
D'Angelo, E. [4 ]
Mescoli, C. [5 ]
Zorzi, M.
Viel, A.
Bruttocao, G.
Ferraro, B.
Erroi, F. [6 ]
Contin, P. [1 ,2 ]
De Salvo, G. L. [7 ]
Nitti, D. [1 ,2 ]
机构
[1] Univ Padua, Clin Chirurg 2, Dipartimento Sci Chirurg Oncol & Gastroenterol, Padua, Italy
[2] Policlin Padua, I-35128 Padua, Italy
[3] Methodist Hosp, Dept Nanomed, Res Inst, Houston, TX 77030 USA
[4] Ist Ric Pediat, Padua, Italy
[5] Univ Padua, Serv Anat Patol, Padua, Italy
[6] Univ Padua, Clin Chirurg 3, Padua, Italy
[7] IOV IRCCS, Serv Epidemiol Clin, Padua, Italy
关键词
Lynch syndrome; Incidence of familial CRCs; Genetics screening; INTERNATIONAL-COLLABORATIVE-GROUP; MICROSATELLITE-INSTABILITY; GERMLINE MUTATIONS; MYH GENE; HEREDITARY; CRITERIA; IMMUNOHISTOCHEMISTRY; FAMILIES; HNPCC; PREDISPOSITION;
D O I
10.1007/s13277-011-0312-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The reported incidence of hereditary colorectal cancers (CRCs) is widely variable. The principal aim of the study was to prospectively evaluate the incidence of familial CRCs in a region of northern Italy using a standardized method. Consecutive CRC patients were prospectively enrolled from October 2002 to December 2003. Patients underwent a structured family history, the microsatellite instability (MSI) test and a screen for MUTYH mutations. Following family history patients were classified as belonging to high, moderate and mild risk families. Immunohistochemistry for MLH1, MSH2, MSH6 and PMS2 proteins and investigation for MLH1/MSH2 mutations, for MLH1 promoter methylation and for the V600E hotspot BRAF mutation were performed in high MSI (MSI-H) cases. Of the 430 patients enrolled, 17 (4%) were high risk [4 hereditary non-polyposis colorectal cancer (HNPCC), 12 suspected HNPCC and 1 MUTYH-associated adenomatous polyposis coli (MAP)], 53 moderate risk and 360 mild risk cases. The MSI test was performed on 393 tumours, and 46 (12%) of them showed MSI-H. In these patients, one MLH1 pathogenetic mutations and two MSH2 pathogenetic mutations were found. Thirty-two (70%) MSI-H cases demonstrated MLH1 methylation and/or BRAF mutation: None of them showed MLH1/MSH2 mutation. Two biallelic germline MUTYH mutations were found, one with clinical features of MAP. A strong family history of CRC was present in 4% of the enrolled cases; incidence of MLH1/MSH2 or MUTHY mutations was 1.3% and of MSI-H phenotype was 12%. MLH1 methylation and BRAF mutation can exclude 70% of MSI-H cases from gene sequencing.
引用
收藏
页码:857 / 864
页数:8
相关论文
共 3 条
  • [1] Performance of clinical guidelines compared with molecular tumour screening methods in identifying possible Lynch syndrome among colorectal cancer patients: a Norwegian population-based study
    Trano, G.
    Sjursen, W.
    Wasmuth, H. H.
    Hofsli, E.
    Vatten, L. J.
    BRITISH JOURNAL OF CANCER, 2010, 102 (03) : 482 - 488
  • [2] Performance of clinical guidelines compared with molecular tumour screening methods in identifying possible Lynch syndrome among colorectal cancer patients: a Norwegian population-based study
    G Tranø
    W Sjursen
    H H Wasmuth
    E Hofsli
    L J Vatten
    British Journal of Cancer, 2010, 102 : 482 - 488
  • [3] Universal testing for MSI/MMR status in colorectal and endometrial cancers to identify Lynch syndrome cases: state of the art in Italy and consensus recommendations from the Italian Association for the Study of Familial Gastrointestinal Tumors (AIFEG)
    Tibiletti, Maria Grazia
    Carnevali, Ileana
    Calo, Valentina
    Cini, Giulia
    Cordisco, Emanuela Lucci
    Remo, Andrea
    Urso, Emanuele
    Oliani, Cristina
    Ranzani, Guglielmina Nadia
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2022, 31 (01) : 44 - 49